查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1877507

2025年人工智慧（AI）賦能的遠距患者靜脈輸液（IV）監測市場報告

Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場發展迅猛，預計將從2024年的13.9億美元成長到2025年的16.9億美元，複合年成長率（CAGR）達21.8%。過去幾年的成長可歸因於以下幾個因素：需要長期輸液的慢性病患者增多、輸液中心從住院轉向門診、腫瘤和免疫學領域生物療法的普及、疫情後遠距醫療模式的推廣，以及由於護理人員短缺而導致的遠距監測需求增加。

人工智慧 (AI) 賦能的遠端患者靜脈輸液 (IV) 監測市場預計將在未來幾年快速成長，到 2029 年達到 36.7 億美元，複合年成長率 (CAGR) 為 21.4%。預測期內的成長要素包括居家醫療項目的擴展和普及、癌症治療和自體免疫疾病專用輸液藥物的持續成長、護理人員短缺和職業倦怠日益嚴重、與安全性和療效掛鉤的價值導向型醫療獎勵，以及促進合理家庭輸液的支付方政策。預測期內的關鍵趨勢包括用於檢測外滲和滲漏的電腦視覺技術、用於監測插管部位組織變化的頻譜光學感測技術、用於設備端分析的邊緣人工智慧感測器貼片、用於預測阻塞、在線連續空氣和流量異常的分析模型，以及使用快速醫療互通性資源 (FHIR) 應用程式編程介面實現的電子健康記錄互通性。

遠端醫療服務的擴展預計將推動人工智慧 (AI) 增強型遠距患者靜脈輸液 (IV) 監測市場的成長。遠端醫療服務利用數位通訊技術提供遠端醫療諮詢、監測和治療。新冠疫情期間推出的監管政策和報銷政策提高了醫療服務提供者和患者的可及性和經濟可行性。人工智慧增強型遠距患者靜脈輸液監測透過實現靜脈輸液治療的即時追蹤、併發症的自動檢測、為醫療服務提供者提供可操作的洞察以及與虛擬護理平台的整合，為遠端醫療提供支持，從而確保及時干預、提高患者安全並高效管理居家和門診護理。例如，根據美國非營利組織 FAIR Health Inc. 於 2023 年 4 月發布的一份報告，全國遠端醫療使用率成長了 7.3%，其在醫療索賠中所佔佔有率從 2022 年 12 月的 5.5% 上升至 2023 年 1 月的 5.9%。遠端醫療服務的擴展正在推動人工智慧增強型遠距患者靜脈輸液監測市場的成長。

穿戴式健康技術的廣泛應用預計將推動市場成長。智慧型手錶和健身追蹤器等穿戴式裝置能夠即時監測健康指標。日益增強的健康意識和對即時健康資訊的需求正在推動這些技術的應用。穿戴式健康技術透過持續收集生理數據，支持遠端患者靜脈輸液監測，從而實現異常檢測、最佳化靜脈輸液治療以及及時、個人化的干涉，無需持續的面對面監測。例如，根據英國下議院圖書館2025年4月發布的報告，在2023年至2024年間，英國國家健康與臨床最佳化研究所（NIHR）和英國研究與創新署（UKRI）投資約1500萬美元（1150萬英鎊）用於10個研究計劃，旨在開發穿戴式設備，以幫助殘疾體弱或長期生活能力。因此，穿戴式健康技術的廣泛應用正在促進人工智慧增強型遠端患者靜脈輸液監測市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧 (AI) 增強型遠端患者靜脈輸液 (IV) 監測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：成長率分析
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場表現：規模和成長，2019-2024年
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場預測：規模和成長，2024-2029年，2034年預測
  • 全球人工智慧 (AI) 增強型遠端患者靜脈輸液 (IV) 監測：潛在市場規模 (TAM)

第6章 市場細分

  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：按組件分類，實際結果和預測，2019-2024年、2024-2029年預測、2034年預測
  • 硬體
  • 軟體
  • 服務
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：依部署模式、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 本地部署
  • 雲端基礎的
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：按應用、性能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 醫院
  • 診所
  • 居家醫療環境
  • 門診手術中心
  • 其他用途
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：按最終用戶分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 醫療保健提供者
  • 患者
  • 其他最終用戶
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：按硬體、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 病患監測設備
  • 感測器和輸液泵
  • 通訊設備
  • 資料儲存系統
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：按軟體、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 預測分析軟體
  • 臨床決策支援軟體
  • 遠端監控軟體
  • 資料管理軟體
  • 全球人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：按服務、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 實施和整合服務
  • 維護和支援服務
  • 培訓和教育服務
  • 遠端監控服務

第7章 區域和國家分析

  • 全球人工智慧（AI）賦能的遠距患者靜脈輸液（IV）監測市場：區域分析、預測與趨勢，2019-2024年、2024-2029年預測、2034年預測
  • 全球人工智慧（AI）賦能的遠距患者靜脈輸液（IV）監測市場：國家/地區、市場表現及預測，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：競爭格局
  • 人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：公司概況
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Epic Systems Corporation
  • ICU Medical Inc.
  • InfuSystem Holdings Inc.
  • AlayaCare Inc.
  • Huma Therapeutics Ltd.
  • Health Recovery Solutions Inc.
  • Arcomed AG
  • VitalConnect Inc.
  • Cloud DX Inc.
  • Empatica Srl
  • AccuHealth Inc.
  • Serum Tracker Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：提供新機會的國家
  • 2029年人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：提供新機會的細分市場
  • 2029年人工智慧（AI）賦能的遠端患者靜脈輸液（IV）監測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r39092

Artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring is a system that employs AI algorithms to continuously track and analyze IV therapy data in real time. It can identify irregularities, predict potential complications, and optimize fluid or medication delivery based on patient-specific patterns. The technology combines sensors, data analytics, and automated alerts to enhance safety and efficiency in IV treatment management.

The primary components of AI-enhanced remote patient intravenous (IV) monitoring include hardware, software, and services. Hardware comprises physical equipment and devices that collect, process, and support system operations, such as infusion pumps and wearable patient monitors. These systems can be deployed on-premises or via cloud platforms. They are applied in various settings, including hospitals, clinics, homecare, ambulatory surgical centers, and others, and are used by diverse end-users such as healthcare providers and patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market statistics, including artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry global market size, regional shares, competitors with the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market share, artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry. This artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market size has grown rapidly in recent years. It will grow from $1.39 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases requiring long-term infusions, the shift from inpatient to outpatient infusion centers, growth in oncology and immunology biologic therapies, post-pandemic adoption of remote care models, and nurse staffing shortages creating a greater need for remote oversight.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 21.4%. The growth during the forecast period can be attributed to the expansion of hospital-at-home programs and coverage, continued growth of specialty infusion drugs for oncology and autoimmune diseases, ongoing nursing workforce shortages and burnout, value-based care incentives linked to safety and outcomes, and payer policies encouraging appropriate home-based infusions. Key trends in the forecast period include computer vision-based detection of extravasation and infiltration, multispectral optical sensing to monitor tissue changes at the cannula site, edge AI on sensor patches for on-device analytics, predictive analytics models for occlusions, air-in-line, and flow anomalies, and electronic health record interoperability using Fast Healthcare Interoperability Resources (FHIR) application programming interfaces.

The expansion of telehealth services is expected to drive the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market. Telehealth services utilize digital communication technologies to provide remote medical consultations, monitoring, and treatment. Regulatory changes and reimbursement policies introduced during the COVID-19 pandemic have increased accessibility and financial viability for both providers and patients. AI-enhanced remote patient IV monitoring supports telehealth by enabling real-time tracking of IV therapy, detecting complications automatically, providing actionable insights to healthcare providers, and integrating with virtual care platforms to ensure timely interventions, improved patient safety, and efficient management of home-based and outpatient treatments. For example, in April 2023, FAIR Health Inc., a US-based non-profit organization, reported that national telehealth use increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. The expansion of telehealth services is therefore driving growth in the AI-enhanced remote patient IV monitoring market.

The proliferation of wearable health technologies is expected to propel market growth. Wearable devices such as smartwatches and fitness trackers monitor health metrics in real time. Increasing health awareness and the demand for real-time health insights are driving the adoption of these technologies. Wearable health technologies support remote patient IV monitoring by continuously collecting physiological data, enabling the detection of anomalies, optimization of IV treatments, and timely, personalized interventions without constant in-person supervision. For instance, in April 2025, the UK Parliament's House of Commons Library reported that between 2023 and 2024, the NIHR and UKRI invested approximately USD 15 million (£11.5 million) in 10 research projects developing wearable technologies to support independence for people living with frailty or long-term physical disabilities. The proliferation of wearable health technologies is thus contributing to the growth of the AI-enhanced remote patient IV monitoring market.

Increasing healthcare expenditure is expected to support the growth of the AI-enhanced remote patient IV monitoring market. Rising financial resources in healthcare reflect growing demand for advanced medical technologies and services aimed at improving patient outcomes, enhancing treatment efficiency, and supporting AI-enabled remote monitoring. Higher healthcare expenditure facilitates investment in advanced technologies, digital infrastructure, and staff training to ensure more efficient and accurate patient care. For example, in June 2025, the Centers for Medicare & Medicaid Services reported that in 2023, national health expenditures increased by 7.5% to reach $4.9 trillion, averaging $14,570 per person and representing 17.6% of GDP. Medicare spending rose by 8.1% to $1,029.8 billion, accounting for 21% of total national health expenditures. Increasing healthcare expenditure is therefore driving the growth of the AI-enhanced remote patient IV monitoring market.

Major players in the artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market consists of revenues earned by entities by providing services such as continuous IV flow monitoring, AI-powered predictive analytics, remote patient monitoring, automated alerts and notifications, data management and reporting, telehealth integration, device management and support, and medication management support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market also includes sales of flow meters, pressure transducers, wireless control interfaces for infusion pumps, cloud-integrated drug infusion systems, and AI-enhanced remote monitoring platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Hardware; Software; Services
  • 2) By Deployment Mode: On-Premises; Cloud-Based
  • 3) By Application: Hospitals; Clinics; Homecare Settings; Ambulatory Surgical Centers; Other Applications
  • 4) By End-User: Healthcare Providers; Patients
  • Subsegments:
  • 1) By Hardware: Patient Monitoring Devices; Sensors And Infusion Pumps; Communication Devices; Data Storage Systems
  • 2) By Software: Predictive Analytics Software; Clinical Decision Support Software; Remote Monitoring Software; Data Management Software
  • 3) By Services: Implementation And Integration Services; Maintenance And Support Services; Training And Education Services; Remote Monitoring Services
  • Companies Mentioned: Medtronic plc; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Baxter International Inc.; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Epic Systems Corporation; ICU Medical Inc.; InfuSystem Holdings Inc.; AlayaCare Inc.; Huma Therapeutics Ltd.; Health Recovery Solutions Inc.; Arcomed AG; VitalConnect Inc.; Cloud DX Inc.; Empatica S.r.l.; AccuHealth Inc.; Serum Tracker Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Characteristics

3. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Trends And Strategies

4. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Segmentation

  • 6.1. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hardware
  • Software
  • Services
  • 6.2. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.3. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Other Applications
  • 6.4. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Healthcare Providers
  • Patients
  • Other End-Users
  • 6.5. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Monitoring Devices
  • Sensors And Infusion Pumps
  • Communication Devices
  • Data Storage Systems
  • 6.6. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Analytics Software
  • Clinical Decision Support Software
  • Remote Monitoring Software
  • Data Management Software
  • 6.7. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implementation And Integration Services
  • Maintenance And Support Services
  • Training And Education Services
  • Remote Monitoring Services

7. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 9.1. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 9.2. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 10.1. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 11.1. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 11.2. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 12.1. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 13.1. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 14.1. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 14.2. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 15.1. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 16.1. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 17.1. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 18.1. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 19.1. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 20.1. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 21.1. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 22.1. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 23.1. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 23.2. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 24.1. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 24.2. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 25.1. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 25.2. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 26.1. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 26.2. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 27.1. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 28.1. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 28.2. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

  • 29.1. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Overview
  • 29.2. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. Nipro Corporation
  • 31.4. Epic Systems Corporation
  • 31.5. ICU Medical Inc.
  • 31.6. InfuSystem Holdings Inc.
  • 31.7. AlayaCare Inc.
  • 31.8. Huma Therapeutics Ltd.
  • 31.9. Health Recovery Solutions Inc.
  • 31.10. Arcomed AG
  • 31.11. VitalConnect Inc.
  • 31.12. Cloud DX Inc.
  • 31.13. Empatica S.r.l.
  • 31.14. AccuHealth Inc.
  • 31.15. Serum Tracker Inc.

32. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

34. Recent Developments In The Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market

35. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer